298 related articles for article (PubMed ID: 14586745)
1. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
2. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K; Yamamoto A; Ogawa N; Sekine T; Tamai S; Motoyama O
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[TBL] [Abstract][Full Text] [Related]
3. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
[TBL] [Abstract][Full Text] [Related]
5. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Braun MC; West CD; Strife CF
Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
[TBL] [Abstract][Full Text] [Related]
6. Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children.
Takeda A; Niimura F; Matsutani H
Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):330-5. PubMed ID: 7666598
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of membranoproliferative glomerulonephritis type II and pregnancy: a case report.
Inaba S; Tanizawa T; Igarashi T; Higuchi A; Satou H; Mase D; Asada R; Suzuki Y; Okada T
Clin Nephrol; 1989 Jul; 32(1):10-3. PubMed ID: 2758699
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
9. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
10. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
[TBL] [Abstract][Full Text] [Related]
11. IgG-associated primary glomerulonephritis in children.
Yoshikawa N; Iijima K; Shimomura M; Nakamura H; Ito H
Clin Nephrol; 1994 Nov; 42(5):281-7. PubMed ID: 7851027
[TBL] [Abstract][Full Text] [Related]
12. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
13. [Prominent subepithelial deposits detected on 2nd renal biopsy in a boy with membranoproliferative glomerulonephritis type I: a case report].
Motoyama O; Ohshima M; Kawamura S; Iitaka K
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):247-52. PubMed ID: 7602812
[TBL] [Abstract][Full Text] [Related]
14. Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Ferrario F; Rastaldi MP
J Nephrol; 2004; 17(4):483-6. PubMed ID: 15372408
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological survey of persistent hypocomplementemic glomerulonephritis in children; correlation of DPGN and MPGN type I].
Hattori S; Hiramatsu M; Ushijima T; Karashima S; Furuse A; Matsuda I; Takebayashi S
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):773-81. PubMed ID: 1479716
[TBL] [Abstract][Full Text] [Related]
16. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
Abreo K; Moorthy AV
Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
[TBL] [Abstract][Full Text] [Related]
17. Long-term evolution of patients with isolated C3 mesangial glomerulonephritis.
Calls Ginesta J; Almirall J; Torras A; Darnell A; Revert L
Clin Nephrol; 1995 Apr; 43(4):221-5. PubMed ID: 7606875
[TBL] [Abstract][Full Text] [Related]
18. [Evolution of morphological and clinical changes in mesangial proliferative glomerulonephritis].
Danilewicz M; Kałuzyński A; Wagrowska-Danilewicz M; Bechcińska B; Zabicka H
Wiad Lek; 1992 Jun; 45(11-12):433-5. PubMed ID: 1279900
[TBL] [Abstract][Full Text] [Related]
19. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
[TBL] [Abstract][Full Text] [Related]
20. [A case of hypocomplementemic mesangial proliferative glomerulonephritis progressing to focal membranoproliferation without aggravation of urinalysis].
Okada S; Sasaki Y; Hayashi A; Fukazawa A; Nakagawa T; Utsunomiya Y; Kasagi T
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):469-74. PubMed ID: 10441999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]